Literature DB >> 26689868

Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study.

Sjors Verlaan1, Terry J Aspray2, Juergen M Bauer3, Tommy Cederholm4, Jaimie Hemsworth5, Tom R Hill6, Jamie S McPhee7, Mathew Piasecki7, Chris Seal6, Cornel C Sieber8, Sovianne Ter Borg5, Sander L Wijers5, Kirsten Brandt6.   

Abstract

BACKGROUND & AIM: Sarcopenia, the age-related decrease in muscle mass, strength, and function, is a main cause of reduced mobility, increased falls, fractures and nursing home admissions. Cross-sectional and prospective studies indicate that sarcopenia may be influenced in part by reversible factors like nutritional intake. The aim of this study was to compare functional and nutritional status, body composition, and quality of life of older adults between age and sex-matched older adults with and without sarcopenia.
METHODS: In a multi-centre setting, non-sarcopenic older adults (n = 66, mean ± SD: 71 ± 4 y), i.e. Short Physical Performance Battery (SPPB): 11-12 and normal skeletal muscle mass index, were recruited to match 1:1 by age and sex to previously recruited adults with sarcopenia: SPPB 4-9 and low skeletal muscle mass index. Health-related quality of life, self-reported physical activity levels and dietary intakes were measured using the EQ-5D scale and index, Physical Activity Scale for the Elderly (PASE), and 3-day prospective diet records, respectively. Concentrations of 25-OH-vitamin D, α-tocopherol (adjusted for cholesterol), folate, and vitamin B-12 were assessed in serum samples.
RESULTS: In addition to the defined components of sarcopenia, i.e. muscle mass, strength and function, reported physical activity levels and health-related quality of life were lower in the sarcopenic adults (p < 0.001). For similar energy intakes (mean ± SD: sarcopenic, 1710 ± 418; non-sarcopenic, 1745 ± 513, p = 0.50), the sarcopenic group consumed less protein/kg (-6%), vitamin D (-38%), vitamin B-12 (-22%), magnesium (-6%), phosphorus (-5%), and selenium (-2%) (all p < 0.05) compared to the non-sarcopenic controls. The serum concentration of vitamin B-12 was 15% lower in the sarcopenic group (p = 0.015), and all other nutrient concentrations were similar between groups.
CONCLUSIONS: In non-malnourished older adults with and without sarcopenia, we observed that sarcopenia substantially impacted self-reported quality of life and physical activity levels. Differences in nutrient concentrations and dietary intakes were identified, which might be related to the differences in muscle mass, strength and function between the two groups. This study provides information to help strengthen the characterization of this geriatric syndrome sarcopenia and indicates potential target areas for nutritional interventions.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Frailty; Micronutrient; Observational; Protein; Sarcopenia

Mesh:

Substances:

Year:  2015        PMID: 26689868     DOI: 10.1016/j.clnu.2015.11.013

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  66 in total

1.  Effect on Body Weight, Quality of Life and Appetite Following Individualized, Nutritional Counselling to Home-Living Elderly after Rehabilitation - An Open Randomized Trial.

Authors:  J Andersson; E Hulander; E Rothenberg; P Iversen
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

2.  Low Levels of Branched Chain Amino Acids, Eicosapentaenoic Acid and Micronutrients Are Associated with Low Muscle Mass, Strength and Function in Community-Dwelling Older Adults.

Authors:  S Ter Borg; Y C Luiking; A van Helvoort; Y Boirie; J M G A Schols; C P G M de Groot
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

3.  Nutritional Risk and Quality of Life in Community-Dwelling Elderly: A Cross-Sectional Study.

Authors:  R Damião; J Meneguci; Á da Silva Santos; A Matijasevich; P Rossi Menezes
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  New Horizons in the Treatment of Age-Associated Obesity, Sarcopenia and Osteoporosis.

Authors:  Alexander Kalinkovich; Maria Becker; Gregory Livshits
Journal:  Drugs Aging       Date:  2022-07-04       Impact factor: 4.271

5.  Psoas muscle size as a magnetic resonance imaging biomarker of progression of pancreatitis.

Authors:  Andre E Modesto; Charlotte E Stuart; Jaelim Cho; Juyeon Ko; Ruma G Singh; Maxim S Petrov
Journal:  Eur Radiol       Date:  2020-02-10       Impact factor: 5.315

6.  Frailty and quality of life in adult survivors of childhood cancer.

Authors:  Kirsten K Ness; Carrie R Howell; Kari L Bjornard
Journal:  Expert Rev Qual Life Cancer Care       Date:  2017-03-06

Review 7.  Quality of life assessment in musculo-skeletal health.

Authors:  Charlotte Beaudart; Emmanuel Biver; Olivier Bruyère; Cyrus Cooper; Nasser Al-Daghri; Jean-Yves Reginster; René Rizzoli
Journal:  Aging Clin Exp Res       Date:  2017-06-29       Impact factor: 3.636

8.  The Association between Poor Diet Quality, Physical Fatigability and Physical Function in the Oldest-Old from the Geisinger Rural Aging Study.

Authors:  Brett Davis; Yi-Hsuan Liu; James Stampley; G Craig Wood; Diane C Mitchell; Gordon L Jensen; Xiang Gao; Nancy W Glynn; Christopher D Still; Brian A Irving
Journal:  Geriatrics (Basel)       Date:  2021-04-15

Review 9.  Perspective: Practical Approach to Preventing Subclinical B12 Deficiency in Elderly Population.

Authors:  Alessandra Vincenti; Laura Bertuzzo; Antonio Limitone; Giuseppe D'Antona; Hellas Cena
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

10.  Maternal vitamin B12 in mice positively regulates bone, but not muscle mass and strength in post-weaning and mature offspring.

Authors:  Parminder Singh; Svetalana Telnova; Bin Zhou; Abdalla D Mohamed; Vanessa De Mello; Henning Wackerhage; X Edward Guo; Amulya K Panda; Vijay K Yadav
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-03-24       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.